All the information you need about MEDPHARMACOM to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-08-04 | Partially confidential | 2021-12-31 | Complete |
| 2021-07-02 | Partially confidential | 2020-12-31 | Complete |
| 2020-04-16 | Partially confidential | 2019-12-31 | Complete |
| 2019-07-10 | Partially confidential | 2018-12-31 | Complete |
| 2019-01-14 | Partially confidential | 2017-12-31 | Complete |
| Name | MEDPHARMACOM |
| Siren | 812261535 |
| Closing | 2019-12-31 |
| Registry code | 6901 |
| Registration number | B2020/009087 |
| Management number | 2015B03635 |
| Activity code | 4649Z |
| Closing date n-1 | 2018-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2020-04-16 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 69006 LYON |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AB Establishment Expenses | 1 600.00 | 1 308.00 | 292.00 | 1 600.00 |
AF Concessions, Patents and Similar Rights | 11 200.00 | 8 018.00 | 3 182.00 | 11 200.00 |
AT Other tangible assets | 11 953.00 | 4 931.00 | 7 023.00 | 11 953.00 |
BJ TOTAL (I) | 24 753.00 | 14 256.00 | 10 497.00 | 24 753.00 |
BT Goods | 145 789.00 | 145 789.00 | 145 789.00 | |
BX Customers and related accounts | 151 063.00 | 151 063.00 | 151 063.00 | |
BZ Other receivables | 81 650.00 | 81 650.00 | 81 650.00 | |
CF Cash and cash equivalents | 1 054 286.00 | 1 054 286.00 | 1 054 286.00 | |
CH Prepaid expenses | ||||
CJ TOTAL (II) | 1 432 788.00 | 1 432 788.00 | 1 432 788.00 | |
CO Grand total (0 to V) | 1 457 541.00 | 14 256.00 | 1 443 285.00 | 1 457 541.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 260 000.00 | 260 000.00 | 260 000.00 | |
DD Legal reserve (1) | 26 000.00 | 100.00 | 26 000.00 | |
DG Other reserves | 208 146.00 | 37 724.00 | 208 146.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 403 056.00 | 553 464.00 | 403 056.00 | |
DL TOTAL (I) | 897 202.00 | 851 289.00 | 897 202.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 445.00 | 407.00 | 445.00 | |
DW Advances and down payments received on current orders | 145 620.00 | 11 900.00 | 145 620.00 | |
DX Trade payables and related accounts | 247 501.00 | 261 604.00 | 247 501.00 | |
DY Tax and social security liabilities | 66 831.00 | 204 605.00 | 66 831.00 | |
EA Other liabilities | 85 686.00 | 361 219.00 | 85 686.00 | |
EC TOTAL (IV) | 546 083.00 | 839 734.00 | 546 083.00 | |
EE Grand total (I to V) | 1 443 285.00 | 1 691 023.00 | 1 443 285.00 | |
| 5 - Fixed assets increase - decrease | Gross value at beginning of year - Item by item | Revaluation - Disposals | Acquisition - Gross value at year-end | |
0G ACQUISITIONS Total General Total | 18 860.00 | 5 894.00 | 18 860.00 | |
CZ ACQUISITIONS: Establishment, Development, or Research Expenses | 1 600.00 | 1 600.00 | ||
I4 DECREASES Grand Total | 24 753.00 | |||
IN DECREASES Start-up, development, or research expenses | 1 600.00 | |||
IO DECREASES Total including other intangible assets | 11 200.00 | |||
IY DECREASES Total Tangible Fixed Assets | 11 953.00 | |||
KD ACQUISITIONS Total including other intangible assets | 11 200.00 | 11 200.00 | ||
LN ACQUISITIONS Total Tangible Fixed Assets | 6 060.00 | 5 894.00 | 6 060.00 | |
